Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
EyePoint Pharmaceuticals Inc (EYPT)
NASDAQ:EYPT
RESEARCH TOOLSreports
Holding EYPT?
Track your performance easily
EyePoint Pharmaceuticals (EYPT) Ownership Overview
13.26% Insiders
13.78% Mutual Funds
0.67% Other Institutional Investors
8.77% ETFs
63.51% Public Companies and
Individual Investors
The ownership structure of EyePoint Pharmaceuticals (EYPT) stock is a mix of institutional, retail, and individual investors. Approximately 23.23% of the company’s stock is owned by Institutional Investors, 13.26% is owned by Insiders, and 63.51% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 21, 2024 | Wendy Dicicco Director | xxxxxxxxxxxxx | $19997 |
| Aug 21, 2024 | Goran Ando Director | xxxxxxxxxxxxx | $39750 |
| Aug 21, 2024 | Karen Zaderej Director | xxxxxxxxxxxxx | $99750 |
| Aug 20, 2024 | Nancy Lurker Director | xxxxxxxxxxxxx | $25003 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $699993 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $2017155 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $5570383 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $7636773 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,325,000 | Insider | 12.21% | 99,900,000 | |
| 2,797,646 | Institution | 4.10% | 33,571,752 | |
| 2,236,086 | Institution | 3.28% | 26,833,032 | |
| 2,168,329 | Institution | 3.18% | 26,019,948 | |
| 2,060,936 | Institution | 3.02% | 24,731,232 | |
| 1,276,070 | Institution | 1.87% | 15,312,840 | |
| 938,591 | Institution | 1.38% | 11,263,092 | |
| 877,790 | Institution | 1.29% | 10,533,480 | |
| 670,941 | Institution | 0.98% | 8,051,292 | |
| 640,274 | Institution | 0.94% | 7,683,288 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,168,329 | Institution | 3.18% | 26,019,948 | |
| 2,060,936 | Institution | 3.02% | 24,731,232 | |
| 1,276,070 | Institution | 1.87% | 15,312,840 | |
| 670,941 | Institution | 0.98% | 8,051,292 | |
| 558,536 | Institution | 0.82% | 6,702,432 | |
| 435,923 | Institution | 0.64% | 5,231,076 | |
| 410,899 | Institution | 0.60% | 4,930,788 | |
| 351,408 | Institution | 0.52% | 4,216,896 | |
| 245,698 | Institution | 0.36% | 2,948,376 | |
| 170,599 | Institution | 0.25% | 2,047,188 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,369,680 | Institution | 2.01% | 16,436,160 | |
| 1,559,245 | Institution | 2.29% | 12,458,368 | |
| 800,378 | Institution | 1.17% | 6,395,020 | |
| 550,205 | Institution | 0.81% | 5,953,004 | |
| 260,229 | Institution | 0.38% | 3,122,748 | |
| 207,788 | Institution | 0.30% | 2,493,456 | |
| 228,854 | Institution | 0.34% | 1,828,543 | |
| 145,452 | Institution | 0.21% | 1,691,607 | |
| 113,524 | Institution | 0.17% | 1,362,288 | |
| 165,093 | Institution | 0.24% | 1,319,093 |
FAQ
Who Owns EyePoint Pharmaceuticals Inc (EYPT)?
According to the latest TipRanks data, approximately 0.67% of the company's stock is held by institutional investors, 13.26% is held by insiders, and 63.51% is held by retail investors.
What percentage of EyePoint Pharmaceuticals Inc (EYPT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.67% of EyePoint Pharmaceuticals Inc (EYPT) stock is held by institutional investors.
What percentage of EyePoint Pharmaceuticals Inc (EYPT) stock is held by retail investors?
According to the latest TipRanks data, approximately 63.51% of EyePoint Pharmaceuticals Inc (EYPT) stock is held by retail investors.
Who owns the most shares of EyePoint Pharmaceuticals Inc (EYPT)?
Cormorant Asset Management, LLC owns the most shares of EyePoint Pharmaceuticals Inc (EYPT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.